MTM Flashcards

1
Q

Medication Therapy Management (MTM)

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A distinct service or group of services that optimize therapeutic
outcomes for individual patients that are independent of, but
can occur in conjunction with, the provision of a drug product”

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A strategy, including payment for services rendered, to
incorporate the philosophy of pharmaceutical care into
everyday pharmacy practice for a defined patient population

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It integrates the philosophy and practice of pharmaceutical care
and elements of disease management through the pharmacist’s
provision of personalized drug-related information and
interventions suited to individual patient needs

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A comprehensive framework for all drug-focused patient care
service components of the practice of the pharmacist

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

An all-inclusive review of a patient’s entire drug regimen and a
mechanism to refer and connect with other health professionals
based on the needs of the individual patient

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Patient-centered care services

A

H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Relationship of MTM to disease management, patient counseling, and pharmaceutical care: A framework for all pharmacy practice

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Flow Chart of a Medication Therapy Management Service Model

A

J

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medication Therapy Management Service Model

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medication therapy review (MTR)

A

I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Personal medication record (PMR)

A

_

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Medication-related action plan (MAP)

A

(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intervention and/or referral

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Documentation and follow-up

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmaceutical care

A

,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

patient-centered practice in which the
practitioner assumes responsibility for a patient’s
drug-related needs and is held accountable for this
commitment for the purpose of achieving definite
outcomes through designing, implementing, or
monitoring of a therapeutic plan”

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

is a structure
in which to provide pharmaceutical care

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is a written, individualized, comprehensive medication therapy plan based on clearly defined therapeutic goals

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

PCP is updated with each major change in
patient status

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pharmaceutical care model

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Identify a patient’s actual and potential drug
therapy problems (DTPs)

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prevent potential DTPs from becoming
actual DTPs

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pharmaceutical care process

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Assess

A

K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Care plan

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Evaluation

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

a distinct service or group of services that optimize therapeutic outcomes for individual patients [that] are independent of, but can occur in conjunction with, the provision of a drug product

A

<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Patient counseling

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

phar- macists are expected to offer an explanation of the purpose of the prescribed drug; proper administration, including length of therapy, special directions for use, proper storage, and refill instructions; information on common adverse effects, potential interactions, and contraindications to the use of the drug; and guidance on steps to take given specific outcomes

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Disease management

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Similarities and dif ferences among pharmacist-provided patient counseling, disease management, and MTM

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Patient counseling

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Disease management

A

L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

MTM

A

<

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Patient counseling

Focus

Practitioner–patient communication

Documentation

Practitioner follow-up

Practitioner

A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Disease management

Focus

Practitioner–patient communication

Documentation

Practitioner follow-up

Practitioner

A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

MTM

Focus

Practitioner–patient communication

Documentation

Practitioner follow-up

Practitioner

A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Drug product information

A

K

40
Q

Disease management and use of population guidelines

A

K

41
Q

Patient drug therapy regimen

A

K

42
Q

One way

A

<

43
Q

Two way

A

K

44
Q

Documentation in patient care record required

A

M

45
Q

Pharmacist or other qualified Physician, nurse, pharmacist, Pharmacist or other qualified health care practitioner

A

K

46
Q

The medication therapy review (MTR) is a systematic process of collecting patient-specific information, assessing medication therapies to identify medication-related problems, devel- oping a prioritized list of medication-related problems, and creating a plan to resolve them.

A

K

47
Q

Medication Therapy Review:

A

K

48
Q

Depending on its scope, the MTR may
include the following:

A

L

49
Q

Assessing, on the basis of all relevant clinical
information available to the pharmacist, the patient’s
physical and overall health status, including current
and previous diseases or conditions

A

K

50
Q

Assessing the patient’s values, preferences, quality of
life, and goals of therapy

A

K

51
Q

Assessing cultural issues, education level, language
barriers, literacy level, and other characteristics of
the patient’s communication abilities that could affect
outcomes

A

K

52
Q

• Evaluating the patient to detect symptoms that could
be attributed to adverse events caused by any of his or
her current medications

A

K

53
Q

Interpreting, monitoring, and assessing patient’s
laboratory results

A

K

54
Q

a comprehensive record of the patient’s medications (prescription and nonprescription medications, herbal products, and other dietary supplements).

A

;

55
Q

The personal medication record (PMR)

A

O

56
Q

The PMR, which is intended for use by the patient, may include the following information:30

A

M

57
Q

Medication-Related Action Plan:

A

L

58
Q

patient-centric document containing a list of actions for the patient to use in tracking progress for self-management.

A

K

59
Q

The MAP, which is intended for use by the patient, may
include the following information:

A

L

60
Q

Patient name
• Primary care physician
(Doctor’s name and phone number)
• Pharmacy/pharmacist
(Pharmacy name/pharmacist name and
phone number)
• Date of MAP creation (Date prepared)
• Action steps for the patient: “What I need to do…”
• Notes for the patient: ”What I did and when I did it…”
• Appointment information for follow-up with
pharmacist, if applicable

A

L

61
Q

The pharma- cist provides consultative services and intervenes to address medication-related problems; when necessary, the pharmacist refers the patient to a physician or other healthcare professional.

A

K

62
Q

Examples of circumstances that may require referral include the following:

A

L

63
Q

patient may exhibit potential problems discovered
during the MTR that may necessitate referral for evalu-
ation and diagnosis

A

K

64
Q

patient may require disease management education
to help him or her manage chronic diseases such as
diabetes

A

K

65
Q

patient may require monitoring for high-risk
medications (e.g., warfarin, phenytoin,
methotrexate)

A

K

66
Q

MTM services are documented in a consistent manner, and a follow-up MTM visit is scheduled based on the patient’s medication-related needs, or the patient is transitioned from one care setting to another.

A

L

67
Q

Proper documentation of MTM services may serve several purposes including, but not limited, to the following:

A

L

68
Q

Facilitating communication between the pharmacist
and the patient’s other healthcare professionals regard-
ing recommendations intended to resolve or monitor
actual or potential medication-related problems

A

L

69
Q

Improving patient care and outcomes

A

K

70
Q

Enhancing the continuity of patient care among
providers and care settings

A

K

71
Q

Ensuring compliance with laws and regulations
for the maintenance of patient records

A

K

72
Q

Basic information: address, phone, e-mail, gender, age, ethnicity, education status, patient’s special needs, health plan benefit/insurance coverage

A

K

73
Q

Pertinent patient-reported information: previous medical history, family history, social history, chief complaints, allergies, previous adverse drug reactions

A

K

74
Q

Known allergies, diseases, conditions, laboratory results, vital signs, diagnostic signs, physical exam results, review of systems

A

K

75
Q

A care plan is the healthcare professional’s course of action for helping a patient achieve specific health goals

A

K

76
Q

Communication with other healthcare professionals: recommendations, referrals, and correspondence with other professionals (cover letter, SOAP note)

A

K

77
Q

record of all medications, including prescription and nonprescription medications, herbal products, and other dietary supplements

A

K

78
Q

Patient-centric document containing a list of actions to use in tracking progress for self-management

A

K

79
Q

one or more of the following factors to target patients who are likely to benefit most from MTM services:

A

L

80
Q

Patient has experienced a transition of care, and his or
her regimen has changed

A

K

81
Q

Patient is receiving care from more than one prescriber

A

K

82
Q

Patient is taking ive or more chronic medications
(including prescription and nonprescription medica-
tions, herbal products, and other dietary supplements)

A

K

83
Q

Patient has at least one chronic disease or chronic
health condition (e.g., heart failure, diabetes,
hypertension, hyperlipidemia, asthma, osteoporosis,
depression, osteoarthritis, chronic obstructive
pulmonary disease)

A

L

84
Q

Patient has laboratory values outside the normal range
that could be caused by or may be improved with
medication therapy

A

<

85
Q

Patient has demonstrated nonadherence (including
underuse and overuse) to a medication regimen

A

K

86
Q

Patient has limited health literacy or cultural
differences, requiring special communication
strategies to optimize care

A

K

87
Q

Patient self-identiies and presents with perceived need
for MTM services

A

K

88
Q

Patient is taking high-risk medication(s), including
narrow therapeutic index drugs (e.g., warfarin,
phenytoin, methotrexate)

A

K

89
Q

ASHP believes that a standardized method for the provision of pharmaceutical care should include the following:

A

L

90
Q

The database should include the following sections, each containing specific types of informa- tion to the extent that it is relevant to medication therapy:

A

S

91
Q

Demographic

A

S

92
Q

Administrative

A

R

93
Q

Medical

A

R

94
Q

Medication therapy

A

R

95
Q

Behavioral/lifestyle
formation.

A

F

96
Q

Social/economic

A

S